Search

everythinglearnresearchcommunity

for

Search:↓

Some birth control pills increase young women's risk of blood clots more than others.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

Autologous fat transfer improves hair growth in scarring alopecia and allows for denser hair transplants.

Human skin has less GDNF and its receptor with age.

PRP helps skin heal, possibly through special cells called telocytes.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

The document concludes that individuals with a rare genetic disorder linked to the AEBP1 gene may experience a unique type of hair loss and should be monitored for heart issues.

Digital gangrene can be an initial symptom of late-onset systemic lupus erythematosus.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Early hormones shape sex-specific differences in rat glands.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Long COVID causes lasting symptoms and needs ongoing care.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

More oxygen isn't always better and can sometimes be worse.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Various substances, quitting smoking, and certain topical applications can enhance the survival of skin flaps used in surgery. Oxygen-free radicals play a role in tissue injury, but certain treatments can have beneficial effects.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Forsythiaside A helps reduce brain damage from lack of blood flow by activating certain protective pathways.

Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.

Early hair loss may predict heart disease.

Early treatment of pediatric lupus-related eye issues is crucial to prevent vision loss.

A woman's nail separation was likely caused by poor blood flow, and a treatment for similar conditions might help.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Minoxidil protects brain tissue directly, not by lowering blood pressure.